Skip to main content
Home

Cardiology Associations

This page includes news coverage of cardiology societies and associations. Follow these links for specific cardiology society news pages: American College of Cardiology (ACC), American Heart Association (AHA), American Society of Echocardiography (ASE),  American Society Nuclear Cardiology (ASNC), European Society of Cardiology (ESC), Heart Rhythm Society (HRS), Society for Cardiovascular Angiography Interventions (SCAI), Society of Cardiovascular Computed Tomography (SCCT), Transcatheter Cardiovascular Therapeutics (TCT), and Vascular Interventional Advances (VIVA). 

RSS icon

  • older patient with a doctor at their house

    Persistent mitral regurgitation after TAVR more common among women than men

    The study's authors emphasized that these data should be kept in mind when making treatment decisions for female patients with severe AS. 

  • Heart attack patients treated at for-profit hospitals more likely to be readmitted

    Readmission rates are getting lower over time among patients treated at nonprofit hospitals. At for-profit facilities, meanwhile, readmission rates have stayed relatively unchanged.

  • A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

    High-quality heart failure care is easy to find for many Americans—but care gaps remain

    The Heart Failure Society of America has released a new comprehensive look at HF clinics in the United States. The report includes more than 300 programs that serve approximately 626,000 patients.

  • obesity semaglutide tirzepatide GLP-1 drugs weight loss

    Semaglutide is improving the heart health of millions—but how? Experts are stumped

    “Our analyses could not fully ascribe the effects of semaglutide on cardiovascular disease to known risk factors with any certainty,” one researcher said after exploring years of data. "These results suggest that semaglutide should be considered as a cardiovascular disease reduction drug and not just as a weight loss drug." 

  • artificial intelligence AI heart cardiology

    AI uses routine CT images to evaluate cardiovascular risk

    Researchers have trained a new AI model to read routine medical images and deliver accurate cardiovascular age assessments.

Michiel Voskuil, MD, PhD, an interventional cardiologist and professor at University Medical Center Utrecht in the Netherlands, presented his team’s data on the ACC.26 stage.

PCI before TAVR? In older CAD patients, deferral may be the best approach

Patients with coronary artery disease and severe aortic stenosis often undergo PCI before TAVR. According to new data presented at ACC.26, however, deferring PCI is associated with comparable outcomes as well as a reduced bleeding risk.

Interventional cardiologist Roxana Mehran, MD, officially started her one-year term as the president of the American College of Cardiology (ACC) on the closing day of ACC.26, the group’s annual conference in New Orleans.

Interventional cardiologist Roxana Mehran elected ACC president

A prominent figure in the fields of interventional cardiology and women’s health is now leading the American College of Cardiology.

Adam Greenbaum, MD, presents late-breaking data at ACC.26.

New stroke prevention device for TAVR holds its own in head-to-head battle with Sentinel

A new embolic protection device from Emboline was noninferior to the FDA-approved Sentinel device in terms of safety and efficacy. In addition, it captured much more TAVR-generated debris and was linked to an improved technical success rate. 

Divaka Perera, MD, at ACC.26

‘Practice-changing’ interventional cardiology research grabs ACC.26 spotlight

The second day of the American College of Cardiology’s annual conference started with a series of highly anticipated interventional cardiology trials.

 Stavros V. Konstantinides, MD, PhD, presenting data at ACC.26

Catheter-based treatment linked to major benefits for intermediate-risk PE

New 30-day data presented at ACC.26 helped answer questions cardiologists have had been asking for years. “Thank you for bringing PE into the future," one vascular specialist said from the stage.  

heart ice cool cold freezing frozen

Cold weather responsible for many more stroke and heart attack deaths than heat

While heat consistently gets more attention in terms of public health messaging, new data show just how dangerous the cold can be.

Vascudyne's off-the-shelf conduit for CABG surgeries

New off-the-shelf conduit for CABG shows promise in first-in-human study

A new acellular tissue-engineered vessel developed by Vascudyne could provide surgeons with a safe, effective alternative to saphenous vein grafts.

heart doctors and surgeons working together. top cardiology hospitals in the United States.

Cardiologists lead push for new cath lab radiation safety standards

Several U.S. medical societies have collaborated on a new report advocating for better safety standards in cardiac catheterization labs. As one cardiologist described it, clinicians have shifted from "accepting risk" to "expecting better."

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …22
    • Page 23
    • Page 24
    • Page 25
    • Current page 26
    • Page 27
    • Page 28
    • Page 29
    • Page 30 …
    • Next page Next ›
    • Last page Last »
Displaying 201 - 208 of 1678
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme